Frailty Status as a Novel Risk Stratification Tool in Patients with Acute Pancreatitis.

Area of Science:

• Gastroenterology and Hepatology
• Geriatrics
• Critical Care Medicine

Background:

• Frailty is a recognized predictor of adverse outcomes in diverse medical conditions.
• The impact of frailty on patients with acute pancreatitis (AP) remains under-investigated.
• Understanding frailty's role in AP is crucial for improving patient care.

Purpose of the Study:

• To evaluate the influence of frailty on patient outcomes in acute pancreatitis.
• To determine if frailty status impacts complication rates, mortality, length of stay, and hospitalization costs in AP.

Main Methods:

• Retrospective cohort study using the 2016-2017 National Inpatient Sample (NIS) database.
• Identified 574,895 adult patients with a primary diagnosis of acute pancreatitis.
• Classified patients as frail or non-frail using the Hospital Frailty Risk Score (HFRS); analyzed outcomes via multivariable logistic regression.

Main Results:

• 24.7% of AP patients were identified as frail.
• Frail patients experienced significantly higher rates of composite complications (26.7% vs. 13.3%), cardiovascular, pulmonary, gastrointestinal, and infectious events.
• Frailty was associated with increased mortality (2.0% vs. 0.1%), longer hospital stays (6.5 vs. 3.6 days), and higher costs ($60,136 vs. $31,095).

Conclusions:

• Frailty is a significant independent predictor of adverse outcomes in acute pancreatitis.
• Frailty assessment, alongside existing scoring systems, can enhance risk stratification for AP patients.
• Integrating frailty evaluation into clinical practice may improve management strategies for acute pancreatitis.